A Polymorphism in the Complement Component C1qA Correlates With Prolonged Response Following Rituximab Therapy of Follicular Lymphoma
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-0745
Full Text
Open PDFAbstract
Available in full text
Date
October 15, 2008
Authors
Publisher
American Association for Cancer Research (AACR)